TREK Diagnostic Systems - Magellan Biosciences SitemapContact Information
  Products Technical Information Newsroom Company Information

The New Energy in Microbiology
TREK Diagnostic Systems is a dedicated microbiology company offering blood culture, identification, and susceptibility technologies to provide cost effective improvements in workflow efficiencies, ergonomics, and test result performance, resulting in better solutions for patient care.

Discovery Workshops:
Click here to RSVP for one of our upcoming Discovery Workshops!
Order alamarBlue®
Click here to learn more about alamarBlue, and to place an order!

Product Highlights

Vizion System Vizion® System Provides a Whole New Way to Visually Read and Record MICs.
See the difference with the Vizion System!
more info>

AlamarBlueDon’t Sacrifice Sensitivity for Stability!
alamarBlue® is the only stable resazurin-based product with extended incubation times
more info>

Introducing
the Newest Sensititre® Software Package SWIN Epidemiology Module

Take Comprehensive Reporting to a Whole New Level… Intuitive and Educational!
more info>

 

News Bulletins

  >   TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products

  >   Magellan Diagnostic Businesses to Feature Automated Systems and
Diagnostic Tests at Clinical Lab Expo


  >   FDA Clears Caspofungin (Cancidas®) Susceptibility Testing for TREK Sensititre® YeastOne® in Vitro Diagnostics (IVD) Product Line

Recent Papers

  >   C-011 An Equivalency Study of the Sensititre Dried MIC System Compared with the CLSI Broth Microdilution Reference Method for TR-700 and Comparator Antimicrobials

  >   C-012 A Multi-Site Study Comparing an 18-24h Sensititre Susceptibility System to the CLSI Broth Microdilution Method for Oritavancin Using Fastidious and Non-Fastidious Gram Positive Organisms

  > C-015 A Multi-Site Study of the Sensititre Susceptibility System Compared with the CLSI Microdilution Method for MIC Determination of Gram Negative and Gram Positive Organisms vs. Ceftaroline

  > C-022 A Retrospective Examination of Mycobacteria Recovery Rates from the VersaTREK Automated Microbial Detection System and the MGIT® 960

  > C-048 Resins Do Not Adsorb All Antibiotics at Peak Serum Concentrations, Especially the Newer Betalactam Antibiotics

  > P-1177 Comparison of VersaTREK 528 and BACTEC® 9240 Continuous Monitoring Blood Culturing Systems for the Detection of Clinical Isolates in a Seeded Bottle Study

Customer Profile
St. Anthony’s Adopts Sensititre® ARIS® 2X as Primary AST/ID System

“It has been a pleasure working with an organization that delivers what it promises.”

St. Anthony’s Medical Center is a 767-bed tertiary care facility located in St. Louis, Missouri. I came to the laboratory at St. Anthony’s Medical Center in 2007, where I found a group of bright and eager technologists.

The lab needed a new AST/ID system, so I initiated a search to see what was available. Based on prior experience – and having used two of the available systems – I limited my search to two potential candidates. In comparing the two systems, based on user feedback and literature search, it soon became apparent that the Sensititre ARIS 2X System would be a better fit for the needs of St. Anthony’s Medical Center.

full story>

Note By Maria Ali-Khan, MT (ASCP),
St. Anthony’s Medical Center

Sitemap | Privacy Policy | Terms & Conditions | © TREK Diagnostic Systems